Initial clinical testing of a cannabinoid-based treatment for fibromyalgia and peripheral neuropathic pain, known as  ZYN001, may soon begin,  Zynerba Pharmaceuticals announced. Zynerba, a clinical-stage specialty pharmaceutical, is developing next-gen synthetic cannabinoid treatments formulated ... Read more